Pilot Core (AD/ADRD Focus): Technology Development and Refinement

试点核心（AD/ADRD 重点）：技术开发和完善

• 批准号: 10688423
• 负责人: Quincy Miles Samus
• 金额: $ 27.81万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-30 至 2026-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10688423
• 关键词: Address; Alzheimer' s Disease; Alzheimer' s disease related dementia; American; Artificial Intelligence; Award; Big Data Methods; Biological Markers; Biometry; Businesses; Caregivers; Caring; Collaborations; Conceptions; Contracts; Copyright; Data; Dementia; Development; Devices; Diagnostic; Elderly; Electronic Health Record; Ensure; Environment; Funding; Goals; Health; Image; Information Dissemination; Leadership; Legal patent; Licensing; Machine Learning; Mentors; Natural Language Processing; Personal Satisfaction; Persons; Phase; Pilot Projects; Process; Quality of Care; Research; Research Personnel; Resources; Robotics; Selection Criteria; Series; Sister; Speech; Standardization; Structure; System; Technology; Time; Translations; Urban Population; Validation; advanced dementia; clinical translation; collaborative approach; collaboratory; commercialization; dementia care; design; digital; health disparity; improved; innovation; meetings; member; multidisciplinary; new technology; operation; product development; program dissemination; resilience; rural area; rural underserved; success; technology development

PROJECT SUMMARY/ABSTRACT The goal of Pilot Core (PCA) for Alzheimer's disease/Alzheimer's disease related dementias (AD/ADRD) is to take a multidisciplinary collaborative approach to identify, develop, refine, and disseminate promising technologies that have high potential to improve the health and wellbeing of older Americans living with AD/ADRD and/or their caregivers, with an emphasis on those that can mitigate current disparities in access and delivery of dementia care in the US and globally. Specific aims are to: (1) develop a national call and fund pilot projects focused on the application of AI and machine learning-supported technologies to improve the health and well-being of older adults with AD/ADRD and/or their caregivers; (2) ensure pilot projects are well- designed, timely and rigorous by providing intellectual leadership, oversight, and access to all of the AITC resources; (3) assist in the further development and translation of completed pilot projects into products that will benefit older adults with AD/ADRD and/or their caregivers; and (4) expand the expertise and network of funded investigators focused on advancing dementia - related AI technologies. Pilot projects will use Artificial Intelligence (AI) approaches and technologies to broadly address four key research domains: Person Living with Dementia Care and Engagement; Diagnostics and Assessment; System Management and Administration; and Caregiver and Workforce Support. Projects will be consistent with the overall themes of this AITC and NIA's AD+ADRD Research Implementation Milestones. Projects will use a range of new technologies, adaptations, and/or integration of multiple technologies to address issues within these major domains. These include, but are not limited to, big data analytics, natural language processing, mobile/cloud/smart device technologies, robotics, image and biometrics, digital biomarkers, imaging, and integrated platforms that can host and integrate multiple technologies (e.g. electronic health records combined with administrative and sensed data). The Core features an ambitious research agenda that features a well-qualified, visionary, and multidisciplinary team to advance dementia care quality, access, and delivery through harnessing the potential of new AI, machine learning and other technologies. Our goal is to produce products that address the multifactorial determinants of health and well-being and that can transform care “on the ground” for older adults living with AD/ADRD and their caregivers.

项目概要/摘要 阿尔茨海默病/阿尔茨海默病相关痴呆 (AD/ADRD) 试点核心 (PCA) 的目标是 采取多学科协作方法来识别、开发、完善和传播有前途的 具有很大潜力改善美国老年人的健康和福祉的技术 AD/ADRD 和/或其照顾者，重点关注那些能够缓解当前获取机会差距的人 在美国和全球范围内提供痴呆症护理的具体目标是：(1) 发起全国性号召并设立基金。 试点项目侧重于人工智能和机器学习支持技术的应用，以改善 患有 AD/ADRD 的老年人和/或其照顾者的健康和福祉；(2) 确保试点项目良好； 通过提供智力领导、监督和对所有 AITC 的访问来设计、及时和严格 资源；(3) 协助进一步开发已完成的试点项目并将其转化为产品 将使患有 AD/ADRD 的老年人和/或其照顾者受益；(4) 扩大老年人的专业知识和网络； 资助研究人员专注于推进痴呆症相关人工智能技术。 试点项目将使用人工智能（AI）方法和技术来广泛解决四个关键问题 研究领域：痴呆症患者护理和参与系统； 管理和行政；以及护理人员和劳动力支持项目将与 该 AITC 和 NIA 的 AD+ADRD 研究实施里程碑项目的总体主题将使用 一系列新技术、改编和/或多种技术的集成，以解决其中的问题 这些主要领域包括但不限于大数据分析、自然语言处理、 移动/云/智能设备技术、机器人技术、图像和生物识别、数字生物标记、成像和 可以托管和集成多种技术的集成平台（例如，电子健康记录结合 与管理和感知数据）。 核心以雄心勃勃的研究议程为特色，其中包括高素质、有远见的、多学科的 团队通过利用新人工智能的潜力来提高痴呆症护理的质量、获取和服务， 我们的目标是生产能够解决多因素问题的产品。 健康和福祉的决定因素，并且可以改变对老年人的“实地”护理 AD/ADRD 及其照顾者。